Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15962027 | 1.00 | KDM4E (0.35) | KDM4ECA12CA2 | |
| SCHEMBL9296525 | 0.85 | KDM4E (0.33) | KDM4ECA12CA2 | |
| SCHEMBL10985609 | 0.81 | — | — | |
| SCHEMBL872485 | 0.74 | — | — | |
| SCHEMBL287739 | 0.73 | MEN1 (0.43) | KDM4ECA12CA2 | |
| SCHEMBL15760047 | 0.73 | — | — | |
| SCHEMBL18843045 | 0.72 | — | — | |
| SCHEMBL13547733 | 0.72 | — | — | |
| SCHEMBL6680692 | 0.67 | — | — | |
| SCHEMBL14895032 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4796772-B2 | — | — | 2011-10-19 | — | — | JP | claimed |
| EP-1572773-B1 | ORGANOMETALLIC-FREE POLYURETHANES HAVING LOW EXTRACTABLES | LUBRIZOL ADVANCED MAT INC (US) | 2008-07-09 | — | — | EP | claimed |
| EP-1572773-A1 | ORGANOMETALLIC-FREE POLYURETHANES HAVING LOW EXTRACTABLES | Noveon IP Holdings Corp. (US) | 2005-09-14 | — | — | EP | claimed |
| WO-2004060954-A1 | ORGANOMETALLIC-FREE POLYURETHANES HAVING LOW EXTRACTABLES | NOVEON IP HOLDINGS CORP. (US) | 2004-07-22 | — | — | WO | claimed |
| EP-3545040-B1 | POLYURETHANE, METHOD OF PREPARATION, AND ARTICLE COMPRISING THE POLYURETHANE | UNIV MASSACHUSETTS (US) | 2023-03-15 | — | — | EP | disclosed |
| US-11046806-B2 | Polyurethane, method of preparation, and article comprising the polyurethane | THE UNIVERSITY OF MASSACHUSETTS (US) | 2021-06-29 | — | — | US | disclosed |
| EP-3545040-A1 | POLYURETHANE, METHOD OF PREPARATION, AND ARTICLE COMPRISING THE POLYURETHANE | The University of Massachusetts (US) | 2019-10-02 | — | — | EP | disclosed |
| US-20190256641-A1 | POLYURETHANE, METHOD OF PREPARATION, AND ARTICLE COMPRISING THE POLYURETHANE | THE UNIVERSITY OF MASSACHUSETTS | 2019-08-22 | — | — | US | disclosed |
| WO-2018057488-A1 | POLYURETHANE, METHOD OF PREPARATION, AND ARTICLE COMPRISING THE POLYURETHANE | THE UNIVERSITY OF MASSACHUSETTS (US) | 2018-03-29 | — | — | WO | disclosed |
| US-9804295-B2 | Ophthalmic devices for sustained delivery of active compounds | NOVARTIS AG (CH) | 2017-10-31 | — | — | US | disclosed |
| US-20170307780-A1 | OPHTHALMIC DEVICES FOR SUSTAINED DELIVERY OF ACTIVE COMPOUNDS | ALCON INC. (CH) | 2017-10-26 | — | — | US | disclosed |
| US-9623614-B2 | Method for making contact lenses | NOVARTIS AG (CH) | 2017-04-18 | — | — | US | disclosed |
| US-20060251696-A1 | Ophthalmic devices for sustained delivery of active compounds | ALCON INC. (CH) | 2006-11-09 | — | — | US | disclosed |
| EP-1697437-A2 | CROSSLINKABLE POLYUREA PREPOLYMERS | Novartis AG (CH) | 2006-09-06 | — | — | EP | disclosed |
| WO-2006053777-A1 | CROSSLINKABLE POLY(OXYALKYLENE)-CONTAINING POLYAMIDE PREPOLYMERS | NOVARTIS AG (CH) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006034863-A1 | PAD PRINTING METHOD FOR MAKING COLORED CONTACT LENSES | NOVARTIS AG (CH) | 2006-04-06 | — | — | WO | disclosed |
| US-20060065138-A1 | Pad printing method for making colored contact lenses | NOVARTIS AG (CH) | 2006-03-30 | — | — | US | disclosed |
| WO-2006010612-A1 | WATER-BASED INKS FOR HYDROGEL LENSES | NOVARTIS AG (CH) | 2006-02-02 | — | — | WO | disclosed |
| WO-2005054325-A2 | CROSSLINKABLE POLYUREA PREPOLYMERS | NOVARTIS AG (CH) | 2005-06-16 | — | — | WO | disclosed |
| US-20050113549-A1 | Crosslinkable polyurea prepolymers | ALCON INC. (CH) | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170307780-A1 | OPHTHALMIC DEVICES FOR SUSTAINED DELIVERY OF ACTIVE COMPOUNDS | PDE6H, PDE6C, PDE6D | KDM4E 1533/4885CA12 1878/4885CA2 509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.